Cargando…
Advanced fibrosis is not a negative pretreatment predictive factor for genotype 2 or 3 chronic hepatitis C patients
BACKGROUND/AIMS: Chronic hepatitis C patients with advanced fibrosis have unsatisfactory sustained virological response (SVR) rates. Few data demonstrating the efficacy of combination therapy in chronic hepatitis C patients with advanced fibrosis in South Korea are available. The purpose of this stu...
Autores principales: | Lee, Hyun Seok, Kweon, Young Oh, Tak, Won Young, Park, Soo Young, Kang, Eun Jung, Lee, Yu Lim, Yang, Hae Min, Park, Hyun Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701847/ https://www.ncbi.nlm.nih.gov/pubmed/23837139 http://dx.doi.org/10.3350/cmh.2013.19.2.148 |
Ejemplares similares
-
Daclatasvir and asunaprevir combination therapy for patients with chronic hepatitis C virus genotype 1b infection in real world
por: Oh, Jae Young, et al.
Publicado: (2019) -
Effect of switching from nucleos(t)ide maintenance therapy to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomized trial
por: Woo, Hyun Young, et al.
Publicado: (2022) -
Evaluating the efficacy of switching from lamivudine plus adefovir to tenofovir disoproxil fumarate monotherapy in lamivudine-resistant stable hepatitis B patients
por: Lee, Heon Ju, et al.
Publicado: (2018) -
Exendin-4 Inhibits Hepatic Lipogenesis by Increasing β-Catenin Signaling
por: Seo, Mi Hae, et al.
Publicado: (2016) -
Multicenter Analysis of Clinical Features and Prognosis of COVID-19 Patients with Hepatic Impairment
por: Song, Jeong Eun, et al.
Publicado: (2021)